Fentanyl is the most prevalent and the most significant synthetic opioida threat to the United States and will very likely remain the most prevalent synthetic opioid threat in the near term. The fentanyl threat remains most severe in the white powder heroin user market in the Midwest and Northeast United...

As of October 2017, a review of Drug Enforcement Administration (DEA) National Forensic Laboratory Information System (NFLIS) data show that cocaine submissions indicate it is the number one seized substance by incident by law enforcement officials in South Carolina. The number of submissions has fluctuated with a high of 4,764...

In June and July 2017, law enforcement authorities made multiple undercover purchases of crack cocaine from one dealer in Baltimore, MD. In September 2017, official laboratory results indicated that two of these purchases tested as N-ethylpentylone Hydrochloride, a synthetic cathinone (“bath salts”) derivative classified as a Schedule I Controlled Substance...

This document is an internal Drug Enforcement Administration quality system document. The effective period of this document is April 24, 2018 to September 9, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 23, 2018 to October 7, 2019 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents...